Evidence map›Paper›PMID 37246344›Full record

ArticleCancer2023

An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry.

Adam B Murphy

Abstract readEditorialComment
In one paragraph

Article in Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Adam B MurphyDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0001-9977-3473

Funding

Using Prostate Health Index and MRI in Combination for Cost-effectively Detecting High-Grade Prostate Cancer in MinoritiesR01CA249973 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MURPHY, ADAM B · 2020 to 2025
$2.9M
NCI NIH HHS R01 CA249973
6 · The paper itself

Abstract

This editorial highlights key findings from the manuscript entitled "Experience with the US health care system for Black and White patients with advanced prostate cancer" in the Cancer journal. Namely, the Black men and White men recruited in US sites for the International Registry for Men with Advanced Prostate Cancer (IRONMAN) registry reported similar and mainly affirmative responses for health care quality metrics on a survey. In non-National Cancer Institute-designated centers, the care was actually worse for the White participants than for the Black participants. The study's results suggest that clinical trial enrollment may be a way to improve health care quality and eliminate disparities for Black men. Whether this healthcare quality benefit extends beyond the few IRONMAN recruitment sites where Black men were recruited or beyond a few measures of healthcare quality remains to be seen.

Indexed as

Prostatic NeoplasmsQuality of Health CareBenchmarkingBlack or African AmericanHumansMaleRegistriesWhite

Identifiers

PMID37246344
PMCPMC12128201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.